@article {Elvs{\r a}shagen2020.09.16.20192898, author = {Torbj{\o}rn Elvs{\r a}shagen and Alexey Shadrin and Oleksandr Frei and Dennis van der Meer and Shahram Bahrami and Vinod Jangir Kumar and Olav Smeland and Lars T. Westlye and Ole A. Andreassen and Tobias Kaufmann}, title = {Genome-wide association analysis of the human thalamus identifies novel genomic loci and reveals genetic overlap with distinct cortical regions and ten brain disorders}, elocation-id = {2020.09.16.20192898}, year = {2020}, doi = {10.1101/2020.09.16.20192898}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The thalamus is a vital communication hub in the center of the brain and consists of distinct nuclei critical for consciousness and higher-order cortical functions1-8. Structural and functional thalamic alterations are involved in the pathogenesis of common brain disorders9-12, yet the genetic architecture of the thalamus remains largely unknown. Here, using brain scans and genotype data from 30,114 individuals, we identified 42 (41 novel) genetic loci and 392 genes associated with volumes of the thalamus and its nuclei. In an independent validation sample (n = 5,173) 96\% of the loci showed the same effect direction (sign test, P = 8.6e-14). We mapped the genetic relationship between thalamic nuclei and 180 cerebral cortical areas and found overlapping genetic architectures consistent with thalamocortical connectivity. Pleiotropy analyses between thalamic volumes and ten psychiatric and neurological disorders revealed shared variants for all disorders. Together, these analyses identify the first genetic loci linked to thalamic nuclei and substantiate the emerging view of the thalamus having central roles in cortical functioning and common brain disorders.Competing Interest StatementT.E. received speakers honoraria from Lundbeck and Janssen Cilag. O.A.A. is a consultant to HealthLytix and received speakers honorarium from Lundbeck.Funding StatementThe authors were funded by the South-Eastern Norway Regional Health Authority 2015-078 (T.E.), 2013-123 (O.A.A.), 2014-097 (L.T.W.), 2015-073 (L.T.W.) and 2016-083 (L.T.W.), by the Research Council of Norway (276082 LifespanHealth (T.K.), 213837 (O.A.A), 223273 NORMENT (O.A.A.), 204966 (L.T.W.), 229129 (O.A.A.), 249795 (L.T.W.), 273345 (L.T.W.) and 283798 SYNSCHIZ (O.A.A.)), Stiftelsen Kristian Gerhard Jebsen, the European Research Council (ERCStG 802998 BRAINMINT (L.T.W.)), NVIDIA Corporation GPU Grant (T.K.), the Ebbe Froland foundation (T.E.), and a research grant from Mrs. Throne-Holst (T.E.). This research has been conducted using the UK Biobank Resource (access code 27412, https://www.ukbiobank.ac.uk/) and we would like to thank the research participants and employees of the UK Biobank. We also thank the ADHD, ASD, SCZ, BD, and MD Working Groups of the Psychiatric Genomics Consortium, the International Genomics of Alzheimer{\textquoteright}s Project, the International Multiple Sclerosis Genetics Consortium, International Parkinson Disease Genomics Consortium, The International League Against Epilepsy Consortium on Complex Epilepsies, and 23andMe, Inc. for granting us access to their GWAS summary statistics, and the many people who provided DNA samples for their studies. This work was performed on the TSD (Tjeneste for Sensitive Data) facilities, owned by the University of Oslo, operated and developed by the TSD service group at the University of Oslo, IT-Department (USIT) and on resources provided by UNINETT Sigma2 - the National Infrastructure for High Performance Computing and Data Storage in Norway.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The National Health Service National Research 411 Ethics Service (ref. 11/112 NW/0382) has approved the UK Biobank and all participants gave signed informed consent before study inclusion. The projects from which summary statistics of GWAS were used for genetic overlap analysis were each approved by the local ethics committees, and informed consent was obtained from all participants (these works are cited in the main text file). The Norwegian Regional Committees for Medical and Health Research Ethics (REC South East) evaluated our pipelines that use summary statistics from published works for genetic analysis as performed in the current study and found that no additional institutional approval is needed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this article were obtained from the UK Biobank [https://www.ukbiobank.ac.uk/], from the Psychiatric Genomics Consortium [https://www.med.unc.edu/pgc/], 23andMe [https://www.23andme.com/], the International Genomics of Alzheimer{\textquoteright}s Project [http://web.pasteur-lille.fr/en/recherche/u744/igap/igap_download.php], the International Multiple Sclerosis Genetics Consortium [http://imsgc.net/], the International Parkinson Disease Genomics Consortium [https://pdgenetics.org/], and from The International League Against Epilepsy Consortium on Complex Epilepsies [https://www.ilae.org/]. The PD GWAS partly included data from the 23andMe consortium and is available through 23andMe to qualified researchers under an agreement with 23andMe that protects the privacy of the 23andMe participants. Please visit research.23andme.com/collaborate/$\#$publication for more information and to apply to access the data.}, URL = {https://www.medrxiv.org/content/early/2020/09/18/2020.09.16.20192898}, eprint = {https://www.medrxiv.org/content/early/2020/09/18/2020.09.16.20192898.full.pdf}, journal = {medRxiv} }